Global Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Market Research Report 2022: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Dublin, Nov. 02, 2022 (GLOBE NEWSWIRE) -- The "Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
'HIV Point of care (POC) Tests Pipeline Report' provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Point of Care Testing (POC) is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care.
Scope
Extensive coverage of the HIV Point of care (POC) Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of HIV Point of care (POC) Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of HIV Point of care (POC) Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 HIV Point of care (POC) Tests Overview
3 Products under Development
3.1 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
3.2 HIV Point of care (POC) Tests - Pipeline Products by Territory
3.3 HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
3.4 HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
3.5 HIV Point of care (POC) Tests - Ongoing Clinical Trials
4 HIV Point of care (POC) Tests - Pipeline Products under Development by Companies
4.1 HIV Point of care (POC) Tests Companies - Pipeline Products by Stage of Development
4.2 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
5 HIV Point of care (POC) Tests Companies and Product Overview
6 Appendix
Companies Mentioned
Abbott Rapid Diagnostics GmbH
Access Bio Inc
Aldatu Biosciences Inc
Altratech Ltd
Atomo Diagnostics Ltd
BBB Technologies Inc
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Binx Health Inc
Bio-AMD Inc
Biocartis Group NV
BioHelix Corp
Bluejay Diagnostics Inc
Calypte Biomedical Corporation
Centre International de Reference Chantal Biya
Cepheid Inc
ChipCare Corp
CrossLife Technologies Inc
Daktari Diagnostics, Inc.
Diagnostics For All Inc
Diagnostics for the Real World (Europe) Ltd
Endeavor Sciences Inc
Epinex Diagnostics Inc
ERBA Molecular Ltd
Fluxergy LLC
GAIA Medical Institute LLC
genedrive plc
Group K Diagnostics
Guangzhou Wondfo Biotech Co Ltd
HeatFlow Technologies Inc
Identifysensors LLC
Imperial College London
Integrated Diagnostics Inc (Inactive)
Jan Biotech Inc
Jinvator Bio Med GmbH
Johns Hopkins University
Maxim Biomedical Inc
MedMira Inc
Micronics Inc
Molbio Diagnostics Pvt Ltd
MyMD Pharmaceuticals, Inc
Nanobiosym Inc
Newmark Diagnostics LLC
Northwestern University
Osel Inc
Prenetics Ltd
QuantuMDx Group Ltd
Quidel Corp
Radisens Diagnostics Ltd
Rheonix Inc
Roche Diagnostics International Ltd
Sedia Biosciences Corp
Senzo Inc
TheoremDx Inc
Trinity Biotech Plc
University of Connecticut
University of Minnesota
UrSure Inc
Ustar Biotechnologies (Hangzhou) Ltd.
Wave 80 Biosciences Inc
Yaathum Biotech Pvt Ltd
For more information about this report visit https://www.researchandmarkets.com/r/k04wv
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900